Piper Sandler Reaffirms “Neutral” Rating for Teleflex (NYSE:TFX)
Piper Sandler reissued their neutral rating on shares of Teleflex (NYSE:TFX – Free Report) in a research note released on Friday, Marketbeat reports. They currently have a $140.00 price target on the medical technology company’s stock, down from their previous price target of $255.00. A number of other research firms also recently weighed in on […]
Piper Sandler reissued their neutral rating on shares of Teleflex (NYSE:TFX – Free Report) in a research note released on Friday, Marketbeat reports. They currently have a $140.00 price target on the medical technology company’s stock, down from their previous price target of $255.00. A number of other research firms also recently weighed in on […]
